A recent study found that urinary tissue inhibitor metal proteinase-2, insulin growth-factor-binding protein-7 (TIMP2*IGFBP7) can be unaffected by pre-existing CKD, enabling the early identification of people at high risk of AKI, especially after cardiac surgery. This evidence concerns the gene TIMP2 and acute kidney injury.